Mirae Asset Global Investments
RCEL icon

Mirae Asset Global Investments’s Avita Medical RCEL Stock Holding History

Mirae Asset Global Investments’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-12,416
Closed -$170K – 2611
2023
Q4 		$170K Hold
12,416
– – ﹤0.01% 2367
2023
Q3 		$181K Hold
12,416
– – ﹤0.01% 2330
2023
Q2 		$211K Buy
+12,416
New +$182K ﹤0.01% 2313

Other funds holding RCEL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
CP
CenterBook Partners Greenwich, Connecticut $1.86B AUM 24.52% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Mirae Asset Global Investments's RCEL Position: Q1 2024 in Review

Mirae Asset Global Investments sold out of Avita Medical (RCEL) in Q1 2024, closing a stake of 12,416 shares — an estimated $170K sold.

Mirae Asset Global Investments first reported a position in RCEL in Q2 2023 and held it in 3 quarters. The position peaked at $211K in Q2 2023. 82 funds tracked by Wall St. Rank hold RCEL as of Q1 2024.

  • Mirae Asset Global Investments reported no remaining Avita Medical position as of Q1 2024 after selling out during the quarter.
  • Mirae Asset Global Investments sold 12,416 Avita Medical shares in Q1 2024, an estimated $170K.
  • Mirae Asset Global Investments first reported a position in Avita Medical in Q2 2023 and held it in 3 quarters.
  • Mirae Asset Global Investments's Avita Medical position peaked at $211K in Q2 2023.
  • 82 funds tracked by Wall St. Rank held Avita Medical as of Q1 2024.

Based on Mirae Asset Global Investments's 13F filing for Q1 2024, filed 1 May 2024.